House David Duane 4

What Happened

• David Duane House, SVP, Finance and Principal Financial Officer of Armata Pharmaceuticals (ARMP), was awarded 109,885 derivative securities reported as acquired at $0.00 on 2026-03-09. The filing classifies the grant as an award/derivative (stock options) rather than an open-market buy or sale.

Key Details

• Transaction date: 2026-03-09; filing date: 2026-03-11 (timely).
• Instrument: derivative award reported at $0.00 (stock options per footnote).
• Quantity: 109,885 shares underlying the award.
• Vesting: 25% of the stock options vest on March 9 of each year 2027, 2028, 2029 and 2030, subject to continued service (per footnote).
• Ownership after transaction: not specified in the provided filing excerpt.
• No indication of immediate sale or cashless exercise; this is a compensation grant, not an open-market trade.

Context

• This is a typical executive compensation grant: options vest over four years and represent future potential equity, not an immediate purchase of shares. Such awards are common for retention/incentive purposes and do not by themselves indicate buying or selling sentiment.